Hippocampal glutathione depletion with enhanced iron level in patients with mild cognitive impairment and Alzheimer's disease compared with healthy elderly participants.
Pravat Kumar MandalAnshika GoelAshley I BushKhushboo PunjabiShallu JoonRitwick MishraManjari TripathiArun GargNatasha K KumarPooja SharmaDeepika ShuklaScott Jonathan AytonAmir FazlollahiJoseph C MaroonDivya DwivediAvantika SamkariaKanika SandalKanu MeghaSandhya ShandilyaPublished in: Brain communications (2022)
Oxidative stress has been implicated in Alzheimer's disease, and it is potentially driven by the depletion of primary antioxidant, glutathione, as well as elevation of the pro-oxidant, iron. Present study evaluates glutathione level by magnetic resonance spectroscopy, iron deposition by quantitative susceptibility mapping in left hippocampus, as well as the neuropsychological scores of healthy old participants ( N = 25), mild cognitive impairment ( N = 16) and Alzheimer's disease patients ( N = 31). Glutathione was found to be significantly depleted in mild cognitive impaired ( P < 0.05) and Alzheimer's disease patients ( P < 0.001) as compared with healthy old participants. A significant higher level of iron was observed in left hippocampus region for Alzheimer's disease patients as compared with healthy old ( P < 0.05) and mild cognitive impairment ( P < 0.05). Multivariate receiver-operating curve analysis for combined glutathione and iron in left hippocampus region provided diagnostic accuracy of 82.1%, with 81.8% sensitivity and 82.4% specificity for diagnosing Alzheimer's disease patients from healthy old participants. We conclude that tandem glutathione and iron provides novel avenue to investigate further research in Alzheimer's disease.